6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: Can-Fite BioPharma Ltd.
Filed: June 7, 2024
Period of Report: June 7, 2024
Accession Number: 0001213900-24-050777

View Document ↗ View on SEC.gov ↗